A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

Clinical trial NCT03933943 · COMPLETED

Trial details

NCT number: NCT03933943
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2019-05-21
Primary completion: 2021-02-15
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.